190 related articles for article (PubMed ID: 16438646)
1. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.
Rakoff-Nahoum S; Kuebler PJ; Heymann JJ; E Sheehy M; Ortiz GM; S Ogg G; Barbour JD; Lenz J; Steinfeld AD; Nixon DF
AIDS Res Hum Retroviruses; 2006 Jan; 22(1):52-6. PubMed ID: 16438646
[TBL] [Abstract][Full Text] [Related]
2. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.
Sauter M; Schommer S; Kremmer E; Remberger K; Dölken G; Lemm I; Buck M; Best B; Neumann-Haefelin D; Mueller-Lantzsch N
J Virol; 1995 Jan; 69(1):414-21. PubMed ID: 7983737
[TBL] [Abstract][Full Text] [Related]
3. Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability.
Hahn S; Ugurel S; Hanschmann KM; Strobel H; Tondera C; Schadendorf D; Löwer J; Löwer R
AIDS Res Hum Retroviruses; 2008 May; 24(5):717-23. PubMed ID: 18462078
[TBL] [Abstract][Full Text] [Related]
4. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines.
Büscher K; Trefzer U; Hofmann M; Sterry W; Kurth R; Denner J
Cancer Res; 2005 May; 65(10):4172-80. PubMed ID: 15899808
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary dynamics of the human endogenous retrovirus family HERV-K inferred from full-length proviral genomes.
Costas J
J Mol Evol; 2001 Sep; 53(3):237-43. PubMed ID: 11523010
[TBL] [Abstract][Full Text] [Related]
6. [Antibodies to stuctural proteins of endogenous retrovirus of the HERV-K/HTDV family as markers of human germ cell tumors].
Seniuta NB; Kleĭman AM; Triakin AA; Karseladze AI; Shelepova VM; Tiuliandin SA; Gurtsevich VE
Vopr Virusol; 2006; 51(3):17-21. PubMed ID: 16826751
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid substitution in a segment of the CA protein within Gag that has similarity to human immunodeficiency virus type 1 blocks infectivity of a human endogenous retrovirus K provirus in the human genome.
Heslin DJ; Murcia P; Arnaud F; Van Doorslaer K; Palmarini M; Lenz J
J Virol; 2009 Jan; 83(2):1105-14. PubMed ID: 19004950
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS.
Goedert JJ; Sauter ME; Jacobson LP; Vessella RL; Hilgartner MW; Leitman SF; Fraser MC; Mueller-Lantzsch NG
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):293-6. PubMed ID: 10207631
[TBL] [Abstract][Full Text] [Related]
9. Insertional polymorphisms of full-length endogenous retroviruses in humans.
Turner G; Barbulescu M; Su M; Jensen-Seaman MI; Kidd KK; Lenz J
Curr Biol; 2001 Oct; 11(19):1531-5. PubMed ID: 11591322
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.
Reis BS; Jungbluth AA; Frosina D; Holz M; Ritter E; Nakayama E; Ishida T; Obata Y; Carver B; Scher H; Scardino PT; Slovin S; Subudhi SK; Reuter VE; Savage C; Allison JP; Melamed J; Jäger E; Ritter G; Old LJ; Gnjatic S
Clin Cancer Res; 2013 Nov; 19(22):6112-25. PubMed ID: 24081977
[TBL] [Abstract][Full Text] [Related]
11. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
Wang-Johanning F; Liu J; Rycaj K; Huang M; Tsai K; Rosen DG; Chen DT; Lu DW; Barnhart KF; Johanning GL
Int J Cancer; 2007 Jan; 120(1):81-90. PubMed ID: 17013901
[TBL] [Abstract][Full Text] [Related]
12. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
[TBL] [Abstract][Full Text] [Related]
13. Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.
Jones RB; John VM; Hunter DV; Martin E; Mujib S; Mihajlovic V; Burgers PC; Luider TM; Gyenes G; Sheppard NC; Sengupta D; Tandon R; Yue FY; Benko E; Kovacs C; Nixon DF; Ostrowski MA
Clin Vaccine Immunol; 2012 Feb; 19(2):288-92. PubMed ID: 22205657
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of an infectious human endogenous retrovirus.
Lee YN; Bieniasz PD
PLoS Pathog; 2007 Jan; 3(1):e10. PubMed ID: 17257061
[TBL] [Abstract][Full Text] [Related]
15. Human endogenous retrovirus family HERV-K(HML-5): status, evolution, and reconstruction of an ancient betaretrovirus in the human genome.
Lavie L; Medstrand P; Schempp W; Meese E; Mayer J
J Virol; 2004 Aug; 78(16):8788-98. PubMed ID: 15280487
[TBL] [Abstract][Full Text] [Related]
16. Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
Jones RB; Leal FE; Hasenkrug AM; Segurado AC; Nixon DF; Ostrowski MA; Kallas EG
J Negat Results Biomed; 2013 Jan; 12():3. PubMed ID: 23305161
[TBL] [Abstract][Full Text] [Related]
17. Variant splicing and influence of ionizing radiation on human endogenous retrovirus K (HERV-K) transcripts in cancer cell lines.
Agoni L; Lenz J; Guha C
PLoS One; 2013; 8(10):e76472. PubMed ID: 24204631
[TBL] [Abstract][Full Text] [Related]
18. Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors.
Herbst H; Sauter M; Mueller-Lantzsch N
Am J Pathol; 1996 Nov; 149(5):1727-35. PubMed ID: 8909261
[TBL] [Abstract][Full Text] [Related]
19. Human endogenous retrovirus HERV-K14 families: status, variants, evolution, and mobilization of other cellular sequences.
Flockerzi A; Burkhardt S; Schempp W; Meese E; Mayer J
J Virol; 2005 Mar; 79(5):2941-9. PubMed ID: 15709013
[TBL] [Abstract][Full Text] [Related]
20. Genomic flexibility of human endogenous retrovirus type K.
Dube D; Contreras-Galindo R; He S; King SR; Gonzalez-Hernandez MJ; Gitlin SD; Kaplan MH; Markovitz DM
J Virol; 2014 Sep; 88(17):9673-82. PubMed ID: 24920813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
